ISO/IEC 27001 Implementation & Certification Advisory

End-to-end Information Security Management System (ISMS) implementation aligned with ISO/IEC 27001:2022 and Annex A controls — delivered by Lead Implementer and Lead Auditor certified consultants.

Why ISO/IEC 27001

ISO/IEC 27001 is the internationally recognised standard for information security management. Certification provides demonstrable assurance to customers, regulators, and insurers that an organisation has implemented a risk-based, systematically managed approach to protecting information assets. It is increasingly a prerequisite for participation in regulated supply chains (banking, defence, healthcare, public sector) and for cross-border data transfers under GDPR.

Engagement Scope

  • Gap assessment against ISO/IEC 27001:2022 clauses 4–10 and Annex A (93 controls)
  • ISMS scope definition and Statement of Applicability (SoA)
  • Risk assessment and treatment using ISO/IEC 27005 methodology
  • Policy and procedure framework — information security, access control, cryptography, supplier relationships, incident management, business continuity
  • Annex A control implementation across the four themes: organisational, people, physical, technological
  • Internal audit by independent senior auditors
  • Management review facilitation
  • Certification body liaison and Stage 1 / Stage 2 audit support

2013 → 2022 Transition

ISO/IEC 27001:2022 introduces eleven new Annex A controls — including threat intelligence, ICT readiness for business continuity, data masking, monitoring activities, web filtering, secure coding, and cloud services security. We support organisations transitioning from the 2013 edition with control-mapping, evidence-gap analysis, and remediation planning.

Integrated Programmes

ISMS implementation can be integrated with:

  • ISO/IEC 27701 (PIMS) — for organisations with GDPR or KVKK obligations
  • ISO/IEC 22301 — for business continuity programmes
  • ISO/IEC 20000 — for IT service management
  • NIST CSF 2.0 — for organisations with U.S. regulatory exposure